Cellular Dynamics International to Present at 30th Annual JPMorgan Healthcare Conference
MADISON, Wis., Jan. 4, 2012 /PRNewswire/ -- Cellular Dynamics International, Inc. (CDI), the world's largest commercial producer of human induced pluripotent stem (iPS) cell lines and tissue cells for drug discovery and safety, today announced that the company is scheduled to present at the 30th Annual JPMorgan Healthcare Conference at 4:00 p.m. PST, Wednesday, January 11, at the Westin St. Francis Hotel in San Francisco. Robert Palay , chief executive officer of CDI, will provide an overview of the company and its emerging business of manufacturing and marketing industrial quantities of iCell Cardiomyocytes, iCell Endothelial Cells, iCell Neurons and a custom reprogramming cell service.
About Cellular Dynamics International, Inc.
Cellular Dynamics International, Inc. (CDI) is a leading developer of next-generation stem cell technologies for drug development, cell therapy, tissue engineering and organ regeneration. CDI harnesses its unique manufacturing technology to produce differentiated tissue cells from any individual's stem cell line in industrial quality, quantity and purity. CDI is accelerating the adoption of pluripotent stem cell technology, adapting its methods to fit into standard clinical practice by the creation of individual stem cell lines from a standard blood draw. CDI was founded in 2004 by Dr. James Thomson, a pioneer in human pluripotent stem cell research at the University of Wisconsin-Madison. CDI's facilities are located in Madison, Wisconsin. See www.cellulardynamics.com.
Senior Director, Marketing & Communications
Cellular Dynamics International, Inc.
Robert E. Flamm , Ph.D.
Russo Partners LLC
Russo Partners LLC
SOURCE Cellular Dynamics International, Inc.
More by this Source
Cellular Dynamics and Coriell Institute for Medical Research Awarded Multi-Million Dollar Grants from California Institute for Regenerative Medicine to Manufacture and Bank Stem Cell Lines
Mar 21, 2013, 08:00 ET
Cellular Dynamics Announces the Production of Human iPSC Lines Under cGMP Conditions
Jan 17, 2013, 08:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.